Inventor
Jian Qiu
Inventor
Longmont, CO, US
Overview
Patents· 51 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
A61KPreparations for medical, dental or toiletry purposes20%
C07CAcyclic or carbocyclic compounds4%
C07BGeneral methods of organic chemistry4%
B01DSeparation3%
C12NMicroorganisms or enzymes3%
C12YEnzymes3%
C08JWorking-up3%
C09DCoating compositions, e.g. paints, varnishes or lacquers3%
PatentTitleYear
10,399,946Solid forms of an S-Nitrosoglutathione reductase inhibitor201910,213,750Hydrophilically modified fluorinated membrane (I)20199,856,219'Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors'20189,828,626Dendrimer conjugates for determining membrane retention level and/or pore structure20179,814,700'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20179,724,650'Hydrophilically modified fluorinated membrane (II)'20179,717,706'Chromone inhibitors of S-nitrosoglutathione reductase'20179,707,212'S-nitrosoglutathione reductase inhibitors'20179,649,603'Hydrophilically modified fluorinated membrane (III)'20179,636,641'Hydrophilically modified fluorinated membrane (I)'20179,498,466'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20169,433,618'Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors'20169,424,855'Audio device and method for adding watermark data to audio signals'20169,364,481'Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors'20169,315,462'Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors'20169,283,229'Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors'20169,283,213'Dihydropyridin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists'20169,249,132'Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors'20169,221,810'Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors'20159,187,447'S-nitrosoglutathione reductase inhibitors'20159,180,119'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20159,139,528'Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors'20159,138,427'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20159,067,893'Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors'20159,029,402'Pyrrole inhibitors of S-nitrosoglutathione reductase'20159,012,646'Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors'20158,957,105'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20158,946,434'Dihydropyridin-2(1H)-one compound as S-nirtosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists'20158,921,562'Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors'20148,906,933'Dihydropyrimidin-2(1H)-one compounds as neurokinin-3 receptor antagonists'20148,846,736'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20148,785,643'Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors'20148,759,548'S-nitrosoglutathione reductase inhibitors'20148,741,915'Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors'20148,691,816'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20148,686,015'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20148,673,961'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20148,669,381'Chromone inhibitors of S-nitrosoglutathione reductase'20148,642,628'Pyrrole inhibitors of S-nitrosoglutathione reductase'20148,626,325'Audio device and method for appending identification data into audio signals'20148,481,590'Chromone inhibitors of S-nitrosoglutathione reductase'20138,470,857'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20138,293,919'Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds'20128,263,661'Development of new selective estrogen receptor modulators'20128,148,380'Antibacterial amide and sulfonamide substituted heterocyclic urea compounds'20128,123,289'Lift chair and a chair frame with a position holding mechanism for use therewith'20127,930,424'System and method for detecting bogus BGP route information'20117,823,202'Method for detecting internet border gateway protocol prefix hijacking attacks'20107,196,119'Development of new selective estrogen receptor modulators'20077,177,271'Method and system for managing admission to a network'20077,030,137'Substituted thiophenes with antibacterial activity'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2019Based in Longmont, CO, US· patent location history
2007–2012Based in Portland, OR, US· patent location history
2010–2011Based in Sunnyvale, CA, US· patent location history
2012–2016Patents assigned to QIU JIAN (15)· patent assignee history
2012–2016Patents assigned to SUN XICHENG (14)· patent assignee history
2012–2014Patents assigned to STRONG SARAH (6)· patent assignee history
2013–2016Patents assigned to N30 PHARMACEUTICALS INC (23)· patent assignee history
2014–2016Based in Shenzhen, CN· patent location history
2015–2018Patents assigned to NIVALIS THERAPEUTICS INC (19)· patent assignee history
2017–2019Based in Oakland Gardens, NY, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| N30 PHARMACEUTICALS INC | 23 | 2013–2016 |
| NIVALIS THERAPEUTICS INC | 19 | 2015–2018 |
| QIU JIANself | 15 | 2012–2016 |
| SUN XICHENG | 14 | 2012–2016 |
| STRONG SARAH | 6 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Longmont, CO, US | 38 | 2006–2019 |
| Oakland Gardens, New York, US | 5 | 2017–2019 |
| Shenzhen, CN | 2 | 2014–2016 |
| Portland, OR, US | 2 | 2007–2012 |
| Sunnyvale, California, US | 2 | 2010–2011 |